The Journal of Medicine Access
Please note that Medicine Access @ Point of Care is now published under the new title The Journal of Medicine Access.
The Journal of Medicine Access is an open access journal delivering the highest quality peer-reviewed articles, reviews and scholarly research on access to medicine. The journal has a clinical focus, providing an online forum for an international audience of pharmacists, clinicians, medical ethicists, regulators and researchers. Please see the Aims and Scopes tab for further information.
This journal a member of the Committee on Publication Ethics (COPE).
Why publish in The Journal of Medicine Access?
- Launched in 2017 as Medicine Access @ Point of Care
- Gold open access journal – all articles are made freely available online immediately upon publication
- Rigorous peer review
- Indexed in the Directory of Open Access Journals (DOAJ)
- Free to publish in for an introductory period
- Reaches a broad, multidisciplinary audience
Diversity, Equity and Inclusion Statement
The Journal of Medicine Access promotes inclusive, open science that reflects the disciplinary, human, and geographic diversity of the research community.
Diversity as a core value embodies inclusiveness, mutual respect, and multiple perspectives.
We welcome editors, editorial board members, peer reviewers and authors from all backgrounds, cultures, ethnicities, nationalities, races, religions, sexes, sexual orientations, gender identities, mental or physical (dis)abilities, ages, career stages, socioeconomic status or any other individual status.
We are committed to continually improving our editorial and review processes whilst playing our part in eradicating bias and inequality in all forms.
Open access article processing charge (APC) information
The article processing charge (APC) is $2100 USD, currently discounted to a rate of $1050.
Submission information
Submit your manuscript today at http://mc.manuscriptcentral.com/maapoc
Please see the Submission Guidelines tab for more information on how to submit your article to the journal.
Contact
Please direct any queries to the Managing Editor, Samantha Taylor (samantha.taylor@sagepub.co.uk)
Other Information
Previously published by Wichtig International Ltd
The Journal of Medicine Access is an open access journal which delivers the highest quality peer-reviewed content dealing with access to medicine in the broadest sense.
The journal is committed to publishing multidisciplinary research that spans the whole spectrum of healthcare and medicine access. The Journal of Medicine Access is aimed at an international audience of pharmacists, clinicians, medical ethicists, regulators, and researchers, providing an online forum for rapid dissemination of recent research and perspectives in this area.
The Editors welcome international contributions particularly from those living in low/middle income countries.
The Journal of Medicine Access covers themes including but not limited to:
- Barriers to Optimal Treatment and Healthcare
- Drug Shortages
- Drug Repurposing
- Expanded Access
- Falsified Medicine
- Global Access to Medicines and Healthcare
- Health Disparities
- Health Services Research, Administration, and Patient Care
- Point of Care Testing
- Policy
- Reimbursement
- Telemedicine and Digital Health
- Treatment of Rare Diseases / Orphan Drugs
- Unlicensed Medicine
- Unmet Clinical Need
Review articles include expert opinion/perspective, narrative reviews and therapeutic area reviews. Systematic reviews, meta-analyses, post-marketing and health economic and pharmacoeconomic reviews are also welcomed. The appropriate EQUATOR Network reporting guidelines should be followed (e.g. CONSORT for randomized, controlled trials and PRISMA for systematic reviews/meta-analyses).
The journal adheres to a single anonymised peer review process in which the reviewer's name is routinely withheld from the author unless the reviewer requests a preference for their identity to be revealed. Manuscripts are reviewed by at least two referees.
| Suvra Moulick | SAGE Publishing, New Delhi, India |
| John B. Hertig, PharmD, MS, CPPS, FASHP | Butler University College of Pharmacy and Health Sciences, Indianapolis, IN, USA |
| Bernard Naughton PhD | Trinity College Dublin, University of Dublin, Dublin, Ireland |
| Felipe Ades MD, PhD | Hospital Israelita Albert Einstein, Brazil |
| Brianne K. Bakken, PharmD, MHA | University of Iowa, IA, USA |
| Roger Bate MPhil | American Enterprise Institute, USA |
| Reed Beall PhD | University of Calgary, Canada |
| Carl Booth RPh | Airedale NHS Foundation Trust, UK |
| Alan Boyd BSc, MB ChB | The Faculty of Pharmaceutical Medicine, UK |
| Steve Bradshaw MD | Valid Insight, UK |
| Bruce Burnett MSc RPh | University of Central Lancashire, UK |
| Arthur Caplan PhD | NYU School of Medicine, USA |
| Tarik Catic PhD Pharm | Society for Pharmacoeconomics and Outcomes Research, Bosnia and Herzegovina |
| Eduardo Cazap MD, PhD | Latin American and Caribbean Society of Medical Oncology, Argentina |
| Romana Cecchele RPh | Royal Prince Alfred Hospital, Australia |
| Domenico Di Giorgio PhD | Italian Medicines Agency - AIFA, Italy |
| Erin Fox PhD | University of Utah Health Care, USA |
| Roberto Frontini PhD | University of Leipzig, Germany |
| Marybec Griffin PhD, MA, MPH | Rutgers School of Public Health, New Jersey, USA |
| Isabelle Huys PhD | KU Leuven, Belgium |
| Mr. Mike Isles | European Alliance for Access to Safe Medicines, UK |
| Güvenç Koçkaya MD, MSc, PhD | Health Economics & Policy Association, Turkey |
| Jillian Clare Kohler PhD | University of Toronto, Canada |
| Eric Lau RPh | Prince of Wales Hospital and Community Health Services, Australia |
| Laura Lyons RPh | Mater Misericordiae University Hospital, Ireland |
| Timothy Mackey PhD | University of California, San Diego, USA |
| Paola Minghetti PhD | Universita degli Studi di Milano, Italy |
| Elias Mossialos MD, PhD | The London School of Economics and Political Science, UK |
| Wayne Nicholls MBBS, FRACP, MBChB | Children's Health Queensland Hospital and Health Service, Australia |
| Oksana Pyzik MPharm | University College London, UK |
| Barbara Rebesco PhD | ICRRS AOU San Martino IST, National Institute for Cancer Research, Italy |
| Dr. Nicole Redvers ND, MPH | University of North Dakota, North Dakota, USA |
| Valerio Reggi PhD | Universitat Autonoma De Barcelona, Spain |
| Mark Sonderup MMED FRCP | University of Capetown Faculty of Health Sciences and Groote Schuur Hospital, South Africa |
| Stephen Tomlin RPh | Evelina London Children's Hospital, UK |
| Pavle Zelic PharmB | Medicines and Medical Devices Agency of Serbia, Serbia |
| Patrick J.A. Kelly MPH | Brown University School of Public Health, Providence, RI, USA |
Manuscript submission guidelines can be accessed on Sage Journals.